Code | CSB-RA796310A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
IHC | 1:50-1:200 |
The ATP1A1 recombinant monoclonal antibody is prepared using protein and DNA recombinant technologies. To obtain this antibody, a synthesized peptide derived from human ATP1A1 is used to immunize mice. After a certain period of time, the spleen cells of mice are extracted under aseptic conditions, and the cDNA synthesized by RNA reverse transcription is used as a template for PCR amplification of the ATP1A1 antibody gene. The obtained gene is inserted into a vector and transfected into host cells for culture. The ATP1A1 recombinant monoclonal antibody is purified from the supernatant of the cell culture by affinity chromatography and is rigorously verified for human ATP1A1 protein detection in ELISA and IHC experiments.
The ATP1A1 protein is a transmembrane protein that plays a crucial role in maintaining the electrochemical gradient across the cell membrane. It uses ATP hydrolysis to transport sodium ions out of the cell and potassium ions into the cell against their concentration gradients, thereby creating a net negative charge inside the cell. In addition to its role in ion transport, ATP1A1 also plays a role in regulating cell growth, differentiation, and apoptosis. Dysfunction of the ATP1A1 protein has been implicated in a variety of diseases, including hypertension, cardiac arrhythmias, and neurological disorders.
There are currently no reviews for this product.